MedPath

Inherited Susceptible Genes Among Epithelial Ovarian Cancer

Conditions
Ovarian Neoplasm Epithelial
Hereditary Breast and Ovarian Cancer Syndrome
Registration Number
NCT03015376
Lead Sponsor
Peking Union Medical College Hospital
Brief Summary

Purpose: To investigate the prevalence of the germline mutations in the BRCA 1/2 and mismatch repair genes in patients with epithelial ovarian cancer (EOC) and their relatives, and related somatic mutations in tumor tissues in the northern part of china.

Patients and methods: A multicenter prospective study will be hold in the northern part of china form 2017. About 1000 female patients with epithelial ovarian cancer and their ralatives will be tested for germline mutations in the BRCA 1/2 and mismatch repair genes and related somatic mutations in tumor tissues, regardless of the family history.

Study type: Observational Official title: Prevalence study of germline mutations in susceptibility ovarian cancer genes in patients with epithelial ovarian cancer and somatic mutations in their tumor tissures in the northern part of china.

Enrollment: 1000

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
1000
Inclusion Criteria
  1. epithelial ovarian cancer and their relatves
  2. living in the north of Huaihe River in China
  3. being Han Chinese
Exclusion Criteria
  1. non-epithelial ovarian cancer
  2. without specific pathological diagnosis
  3. non-Han Chinese

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
herited gene mutations susceptible to epithelial ovarian cancer in patients and their relativestwo years
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Lei Li

🇨🇳

Beijing, Beijing, China

Peking Union Medical College Hospital

🇨🇳

Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath